Summary of HR 4993 - Joe Fiandra Access to Home Infusion Act of 2025

Overview

The Joe Fiandra Access to Home Infusion Act of 2025 (HR 4993) is a legislative proposal aimed at improving access to home infusion therapy for patients requiring such medical treatments. Introduced in the House of Representatives on August 19, 2025, the bill seeks to enhance the availability and affordability of home infusion services, ensuring that patients can receive necessary medications in the comfort of their homes.

Purpose and Intent

The primary intent of HR 4993 is to:
- Expand Access: Facilitate greater access to home infusion therapy for patients, particularly those with chronic illnesses or conditions that require long-term medication administration.
- Improve Quality of Care: Ensure that patients receive high-quality, safe, and effective home infusion services.
- Reduce Healthcare Costs: Lower overall healthcare costs by decreasing the need for hospital stays and in-person treatments.

Key Provisions

While the specific provisions of the bill are not detailed in the provided information, typical components of such legislation may include:
- Insurance Coverage: Mandating that private insurers and Medicare cover home infusion therapy services.
- Provider Standards: Establishing standards for home infusion providers to ensure safety and quality.
- Patient Education: Implementing programs to educate patients and caregivers about home infusion therapy.
- Reimbursement Models: Creating reimbursement models that incentivize healthcare providers to offer home infusion services.

Affected Parties

The bill would primarily impact:
- Patients: Individuals requiring home infusion therapy, particularly those with chronic conditions.
- Healthcare Providers: Hospitals, infusion therapy providers, and home health agencies that deliver these services.
- Insurance Companies: Entities that would need to adjust their coverage policies to comply with the new requirements.

Legislative Process

• Introduced: August 19, 2025
• Referred to Committees: The bill has been referred to the Committee on Energy and Commerce and the Committee on Ways and Means for consideration. The Speaker of the House will determine the period for review by these committees.

Related Legislation

HR 4993 has companion bills that may address similar issues:
- HR 1768: A related bill in the House.
- S 891: A companion bill in the Senate.

Conclusion

The Joe Fiandra Access to Home Infusion Act of 2025 represents a significant step towards improving access to home-based medical care for patients in need of infusion therapy. By addressing insurance coverage, provider standards, and patient education, the bill aims to enhance the quality of care and reduce healthcare costs associated with traditional treatment settings. As it moves through the legislative process, further details and provisions will likely be clarified.